Mar. 6 at 2:58 PM
$ANAB I expect that the new ANAB (after spinoff) will be a pure royalty company, distributing taxable income. My guess is that its market cap will be something like
$3.5 billion. The biotech spinoff will have a market cap of something like
$700 million. It will be a pure capital gain investment. Therefore, I, as a non-US person will sell the new ANAB as I do not want to experience 30% automatic with holding taxes. I may hold the biotech depending upon pricing. Any observations or comments? JMO
